RPS6KA3 and myeloid sarcoma: Of this subset, 645 RNAs were increased in platelets of MS patients as compared to HCs, including the RNAs EPSTI1 and IFI6, whereas RPS6KA3 had decreased levels in MS patients as compared to HCs (Table 2; Table S2).